U.N. High-Level Panel To Examine How IP, Trade Rules, Human Rights Law Affect Access To Medicines

Global Health Technologies Coalitions’ “Breakthroughs”: Setting the stage: U.N. High-Level Panel on Access to Medicines to consider IP, trade, human rights, and access to medicine
Courtney Carson, GHTC’s senior policy and advocacy associate, discusses the work surrounding the U.N. High-Level Panel on Access to Medicines, which is “designed to consider ways in which intellectual property (IP) protections, trade rules, and international human rights law might affect global access to medicine and the ability of the international community to achieve [Sustainable Development Goal (SDG)] three by 2030” (1/28).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.